8-KAccepted Mar 21, 3:47 PM ET

AXIM BIOTECHNOLOGIES, INC. 8-K

Accepted (ET)

3:47 PM

Mar 21, 2024

Filed

Mar 21, 2024

Documents

Size

313.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.

axim-20240315.htmPrimary
AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
axim_ex10z1.htm
FORM OF CONVERTIBLE NOTE PURCHASE AGREEMENT DATED MARCH 15, 2024
axim_ex10z2.htm
FORM OF VERSION 1 NOTE DATED MARCH 15, 2024
axim_ex10z3.htm
FORM OF VERSION 2 NOTE DATED MARCH 15, 2024
axim_ex10z4.htm
FORM OF VERSION 3 NOTE DATED MARCH 15, 2024
axim_ex10z5.htm
FORM OF STOCK PURCHASE AGREEMENT DATED MARCH 15, 2024
axim-20240315_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
axim-20240315_lab.xml
XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
axim-20240315_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
axim-20240315.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
axim8k_1.jpg
IMAGE
R1.htm
IDEA: XBRL DOCUMENT
Financial_Report.xlsx
IDEA: XBRL DOCUMENT
Show.js
IDEA: XBRL DOCUMENT
report.css
IDEA: XBRL DOCUMENT
FilingSummary.xml
IDEA: XBRL DOCUMENT
MetaLinks.json
IDEA: XBRL DOCUMENT
0001096906-24-000539-xbrl.zip
IDEA: XBRL DOCUMENT
axim-20240315_htm.xml
IDEA: XBRL DOCUMENT